Welcome

This forum is for IRIS Industry users' discussion and self-help. You need to login to the portal with an IRIS account to post a new thread or reply to an existing one.
EMA staff monitors the forum and may intervene in conversation, however a reply cannot be guaranteed. This Forum does not replace the existing communication channels:
  • Questions on ongoing procedures at EMA should be submitted as a reply to any email received from IRIS regarding the specific case.
  • Use this form to send a request for information from the European Medicines Agency or to make a formal request for access to EMA documents that are not already published on the EMA website
  • Problems and technical issues about IRIS should be reported to the EMA ServiceNow. If you have difficulties in obtaining a role or affiliation to access IRIS, please select "IRIS account access and management" as the service, in the specific ServiceNow page.
Please do not post confidential information in the forum.
Thread Author Last post Replies
Scientific advice in IRIS- Applicant and linked organisation information Rainer Paffenholz
Tarita Toufexi
1
Scientific Advice follow up submission Liron Gibbs-Bar
Paolo Tomasi
3
draft briefing document Markas Marcinkevicius
Paolo Tomasi
3
SA Process, Dates of SAWP meetings and IRIS Isha Arora
Paolo Tomasi
1
IRIS INDUSTRY MANAGER ROLE AND LETTER of INTENT vincenzo agozzino
Paolo Tomasi
1
Affiliation Template for First IRIS Industry User Admin Karl-Heinz Loebel
Carlotte Lucas
1
IRIS Scientific Advice Request - linking PIP information Pauline Leslie
Paolo Tomasi
3
Replacing uploaded files in IRIS Ian Hardern
Ian Hardern
2
IRIS Scientific Advice Request Applications - sponsor e-mail address/mailbox Anna-Marie Lord
Paolo Tomasi
1
IRIS for Industry Companies working in Partnership Laurent Desqueper
Paolo Tomasi
3
RPI(s) and co-formulation Laurent Desqueper
Paolo Tomasi
1
Regulatory Entitlement Pilar Pizcueta
Paolo Tomasi
1
Impact of Organization and Location selected when creating a Submission Laurent Desqueper
Paolo Tomasi
1
Orphan designation Annual reporting Liron Gibbs-Bar
Paolo Tomasi
3
Marketing Status reporting - Marketing Status values Roberta Bernardelli
Paolo Tomasi
1
Introduction Paolo Tomasi
Paolo Tomasi
0

You must be signed in to post in this forum.